Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriaki Maruyama is active.

Publication


Featured researches published by Noriaki Maruyama.


Heterocycles | 1993

Porphyrins coupled with nucleoside bases. Synthesis and some properties of guanine, cytosine and adenine-thymine derivatives

Masao Hisadome; Masao Hisatome; Noriaki Maruyama; Koichi Ikeda; Koji Yamakawa

Synthesis of several porphyrin derivatives having a guanine, cytosine or adenine-thymine pair is described. Diamagnetic shift behaviors of the base proton signals in the 1 H-nmr spectra of the derivatives and hypochromism of the Soret band in the electronic spectra are briefly discussed


Biochimica et Biophysica Acta | 2001

Involvement of calcium signaling in the fibronectin-stimulated macrophage recognition of oxidatively damaged erythrocytes.

Masatoshi Beppu; Masayoshi Azuma; Noriaki Maruyama; Kiyomi Kikugawa

Macrophages recognize oxidatively damaged autologous erythrocytes, and cell surface fibronectin of macrophages enhances the recognition (Beppu et al., FEBS Lett. 295 (1991) 135-140). In the present study, mechanisms of enhanced macrophage recognition of oxidatively damaged erythrocytes by fibronectin were investigated. Monolayers of thioglycollate-induced mouse peritoneal macrophages with cell surface fibronectin recognized autologous erythrocytes oxidized with an iron catalyst ADP/Fe(3+). The macrophage recognition of the oxidized erythrocytes was inhibited partially by pretreatment of the macrophage monolayers with a Ca(2+) channel blocker (diltiazem), calmodulin inhibitors (W-7, trifluoperazine, chlorpromazine and dibucaine), an inhibitor of myosin light chain kinase (ML-9), a microfilament formation inhibitor (cytochalasin B), phospholipase A(2) inhibitors (4-bromophenacyl bromide, mepacrine) and cyclooxygenase inhibitors (indomethacin and aspirin). Monolayers of macrophages depleted of fibronectin by trypsinization lost the ability of recognizing oxidized erythrocytes, but acquired the ability when stimulated with a fibronectin-coated coverslip. The recognition of fibronectin-stimulated trypsinized macrophages was also inhibited by the above inhibitors. On treatment with Ca ionophore A23187, trypsinized macrophages acquired the ability to recognize oxidized erythrocytes. The recognition of Ca ionophore-stimulated trypsinized macrophages was inhibited by the above inhibitors except the Ca(2+) channel blocker. These results indicate that the Ca(2+) signaling including Ca(2+) influx, calmodulin activation and myosin light chain phosphorylation are involved in the fibronectin stimulation of the recognition of macrophages for oxidized erythrocytes. Involvement of microfilament formation and arachidonate cascade in the fibronectin stimulation was also suggested.


Journal of Medicinal Chemistry | 1997

Antirheumatic Agents: Novel Methotrexate Derivatives Bearing a Benzoxazine or Benzothiazine Moiety

Hiroharu Matsuoka; Nobuhiro Ohi; Masahiko Mihara; Hiroshi Suzuki; Katsuhito Miyamoto; Noriaki Maruyama; Keiichiro Tsuji; Nobuaki Kato; Toshio Akimoto; Yasuhisa Takeda; Keiichi Yano; Toshio Kuroki


Chemical & Pharmaceutical Bulletin | 1995

Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. V. Thienopyridazinone derivatives.

Masahisa Yamaguchi; Noriaki Maruyama; Takaki Koga; Kenshi Kamei; Toshio Kuroki; Masatomo Hamana; Nobuhiro Ohi


Archive | 1999

Heterocyclic indole derivatives and mono- or diazaindole derivatives

Hiroharu Matsuoka; Nobuaki Kato; Tadakatsu Takahashi; Noriaki Maruyama; Takenori Ishizawa; Yukio Suzuki


Archive | 2005

Indole derivative having heterocycle and mono- or diazaindole derivative

Hiroharu Matsuoka; Nobuaki Kato; Tadakatsu Takahashi; Noriaki Maruyama; Takenori Ishizawa; Yukio Suzuki


Chemical & Pharmaceutical Bulletin | 1996

Synthesis and Some Spectroscopic Properties of Porphyrin Derivatives Connected with Nucleobases (Adenine, Thymine, Guanine and Cytosine)by Alkanamide Chains

Masao Hisatome; Noriaki Maruyama; Koichi Ikeda; Tetsuo Furutera; Tomiyasu Ishikawa; Koji Yamakawa


Chemical & Pharmaceutical Bulletin | 1994

Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. IV. 2-(2-(1-Imidazolyl)ethyl)-4-(3-pyridyl)-1(2H)-phthalazinones.

Masahisa Yamaguchi; Takaki Koga; Kenshi Kamei; Noriaki Maruyama; Toshio Kuroki; Masatomo Hamana; Nobuhiro Ohi


Chemical & Pharmaceutical Bulletin | 1995

Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. VI. Indazole Derivatives

Masahisa Yamaguchi; Noriaki Maruyama; Takaki Koga; Kenshi Kamei; Toshio Kuroki; Masatomo Hamana; Nobuhiro Ohi


Archive | 1998

Indole derivatives and mono- and diazaindole derivatives

Hiroharu Matsuoka; Noriaki Maruyama; Hirotaka Kashiwagi

Collaboration


Dive into the Noriaki Maruyama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nobuaki Kato

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Toshio Kuroki

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Nobuhiro Ohi

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiichiro Tsuji

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kenshi Kamei

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masatomo Hamana

Chugai Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge